Protocol: PK Bridging ELISA For Use With Anti-Infliximab Antibodies
Pharmacokinetic (PK) Bridging ELISA: For use with anti-infliximab monoclonal antibody products HCA212 and HCA213P
This method provides a procedure for carrying out a PK ELISA with anti-infliximab antibodies, product codes HCA212 (capture antibody) and HCA213P (detection antibody), and using infliximab monoclonal antibody for the standard curve.
The method should always be used in conjunction with product and batch specific information provided with each vial (see product datasheets). This protocol will need to be adjusted for use with different detection methods and immunoassay technology platforms.
MaxiSorp™ and QuantaBlu™ are trademarks of Thermo Fisher Scientific.
Tween® is a registered trademark of ICI Americas Inc.
Payment methods we support: